Management of Increased Prothrombin Time

Initial Assessment and Management

The American College of Chest Physicians recommends that the management of a patient with increased prothrombin time depends critically on whether the patient is actively bleeding and the underlying cause, with patients on warfarin with INR 4.5-10 without bleeding requiring simply withholding warfarin, while patients with active bleeding require immediate reversal with vitamin K, fresh frozen plasma, and prothrombin complex concentrates 1, 2, 3
When encountering a patient with prolonged PT, immediately assess the active bleeding status, anticoagulant use, timing of last anticoagulant dose, and concurrent medications, with the American College of Chest Physicians recommending the use of prothrombin complex concentrate over fresh frozen plasma due to higher concentration of clotting factors and less volume 2, 3
The initial assessment should also include checking INR, aPTT, hemoglobin, hematocrit, platelet count, renal function, and fibrinogen levels, with the World Journal of Emergency Surgery recommending maintaining platelet count >75 × 10^9/L (>50,000/mm³ minimum for life-threatening hemorrhage; higher for neurosurgery) 2, 3, 5

For patients on warfarin with INR 4.5-10 without bleeding, the American College of Chest Physicians recommends simply withholding warfarin, as vitamin K does not reduce major bleeding or thromboembolism, with a strength of evidence grade of moderate 1
For patients on warfarin with INR >10 without bleeding, the American College of Chest Physicians recommends administering oral vitamin K 2-2.5 mg, with a prospective case series showing a low rate of major bleeding by 90 days (3.9%; 95% CI, 1.1-9.7) 1
For patients with active bleeding, the American College of Chest Physicians recommends immediately administering all three reversal agents: intravenous vitamin K, prothrombin complex concentrate, and fresh frozen plasma, with the dose of prothrombin complex concentrate depending on the INR level (25 units/kg for INR 2-4, 35 units/kg for INR 4-6, and 50 units/kg for INR >6) 2, 3

For trauma patients, the Praxis Medical Insights recommends a goal-directed approach using a 1:1:1 ratio of RBC:FFP:platelets for massive hemorrhage, with the World Journal of Emergency Surgery recommending maintaining PT/aPTT <1.5 times normal control during interventions for life-threatening hemorrhage or emergency neurosurgery 3, 5
For patients requiring neurosurgery, the World Journal of Emergency Surgery recommends maintaining PT/aPTT <1.5 times normal control, with higher platelet thresholds advisable for ICP probe insertion 5

The Praxis Medical Insights recommends avoiding reflexive transfusion of plasma for asymptomatic prolonged PT, as randomized trials show no reduction in bleeding when prophylactic plasma is given to correct INR values in periprocedural, critically ill, and liver disease patients, with a strength of evidence grade of high 4
The Praxis Medical Insights also recommends avoiding delay in treatment in actively bleeding patients while awaiting laboratory confirmation, with a strength of evidence grade of high 3